Showing results (41-50 of 781) with videos related to
Sort By:
Pageof 79
Cancer Research|October 16, 2003
Effects of oligonucleotide N3'-->P5' thio-phosphoramidate (GRN163) targeting telomerase RNA in human multiple myeloma cellsMasaharu Akiyama, Teru Hideshima, Masood A Shammas, et al.Blood|December 10, 2013
A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistanceZe Tian, Padraig D'Arcy, Xin Wang, et al.Proceedings of the National Academy of Sciences of the United States of America|January 19, 2008
MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myelomaMasahisa Jinushi, Matthew Vanneman, Nikhil C Munshi, et al.Blood|May 27, 2006
Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cellsLaurence Catley, Ellen Weisberg, Tanyel Kiziltepe, et al.Blood|September 16, 2004
Patupilone (epothilone B) inhibits growth and survival of multiple myeloma cells in vitro and in vivoBoris Lin, Laurence Catley, Richard LeBlanc, et al.Clinical Lymphoma, Myeloma & Leukemia|July 7, 2020
Primary Plasma Cell Leukemia: Real-World Retrospective Study of 46 Patients From a Single-Center Study in ChinaTengteng Yu, Yan Xu, Gang An, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Phenotypic and functional effects of heat shock protein 90 inhibition on dendritic cellJooeun Bae, Constantine Mitsiades, Yu-Tzu Tai, et al.Leukemia|July 22, 2021
Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myelomaJooeun Bae, Fabrizio Accardi, Teru Hideshima, et al.Blood|October 7, 2006
Targeting PKC in multiple myeloma: in vitro and in vivo effects of the novel, orally available small-molecule inhibitor enzastaurin (LY317615.HCl)Klaus Podar, Marc S Raab, Jing Zhang, et al.British Journal of Haematology|April 27, 2012
Halofuginone inhibits multiple myeloma growth in vitro and in vivo and enhances cytotoxicity of conventional and novel agentsMerav Leiba, Jana Jakubikova, Steffen Klippel, et al.Pageof 79